These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 36852569)
1. The efficacy of 5HT3-receptor antagonists in postoperative nausea and vomiting: the role of pharmacogenetics. Theodosopoulou P; Rekatsina M; Staikou C Minerva Anestesiol; 2023 Jun; 89(6):565-576. PubMed ID: 36852569 [TBL] [Abstract][Full Text] [Related]
3. Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting. Kim MS; Lee JR; Choi EM; Kim EH; Choi SH Yonsei Med J; 2015 Sep; 56(5):1415-20. PubMed ID: 26256989 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Ho KY; Gan TJ Curr Opin Anaesthesiol; 2006 Dec; 19(6):606-11. PubMed ID: 17093363 [TBL] [Abstract][Full Text] [Related]
5. CYP2D6 basic genotyping as a potential tool to improve the antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting. Niewiński PA; Wojciechowski R; Śliwiński M; Hurkacz ME; Głowacka K; Orzechowska-Juzwenko K; Wiela-Hojeńska AK Adv Clin Exp Med; 2018 Nov; 27(11):1499-1503. PubMed ID: 30058787 [TBL] [Abstract][Full Text] [Related]
7. CYP2D6 isoenzyme and ABCB1 gene polymorphisms associated with postoperative nausea and vomiting in women undergoing laparoscopic cholecystectomy: a randomized trial. Ribeiro AHS; Braga ELC; Ferreira NAG; Olej B; Verçosa N; Antunes LDS; Cavalcanti IL Braz J Anesthesiol; 2024; 74(3):744423. PubMed ID: 36841429 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Ramosetron and Palonosetron for Preventing Nausea and Vomiting after Spinal Surgery: Association With ABCB1 Polymorphisms. Song JW; Shim JK; Choi SH; Soh S; Jang J; Kwak YL J Neurosurg Anesthesiol; 2017 Oct; 29(4):406-414. PubMed ID: 27564555 [TBL] [Abstract][Full Text] [Related]
9. Association of ABCB1 polymorphisms with the efficacy of ondansetron in chemotherapy-induced nausea and vomiting. He H; Yin JY; Xu YJ; Li X; Zhang Y; Liu ZG; Zhou F; Zhai M; Li Y; Li XP; Wang Y; Zhou HH; Liu ZQ Clin Ther; 2014 Aug; 36(8):1242-1252.e2. PubMed ID: 25012726 [TBL] [Abstract][Full Text] [Related]
10. A network meta-analysis on the efficacy of serotonin type 3 receptor antagonists used in adults during the first 24 hours for postoperative nausea and vomiting prophylaxis. Tang DH; Malone DC Clin Ther; 2012 Feb; 34(2):282-94. PubMed ID: 22296947 [TBL] [Abstract][Full Text] [Related]
11. Effect of the allelic variants of ABCB1, CYP2D6 and HTR3B on response of ramosetron to prevent chemotherapy-induced nausea and vomiting in Korean cancer patients. Kang G; Kim KR; Shim HJ; Hwang JE; Bae WK; Chung IJ; Kim HN; Lee J; Choi K; Shin HY; Kim JK; Jeong SW; Cho SH Asia Pac J Clin Oncol; 2017 Feb; 13(1):53-60. PubMed ID: 27488933 [TBL] [Abstract][Full Text] [Related]
12. The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis? Candiotti KA; Birnbach DJ; Lubarsky DA; Nhuch F; Kamat A; Koch WH; Nikoloff M; Wu L; Andrews D Anesthesiology; 2005 Mar; 102(3):543-9. PubMed ID: 15731591 [TBL] [Abstract][Full Text] [Related]
13. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy. Perwitasari DA; Wessels JA; van der Straaten RJ; Baak-Pablo RF; Mustofa M; Hakimi M; Nortier JW; Gelderblom H; Guchelaar HJ Jpn J Clin Oncol; 2011 Oct; 41(10):1168-76. PubMed ID: 21840870 [TBL] [Abstract][Full Text] [Related]
14. The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy. Fujii Y Curr Pharm Des; 2005; 11(24):3173-83. PubMed ID: 16178752 [TBL] [Abstract][Full Text] [Related]
15. Association of ABCB1 polymorphisms with the efficacy of ondansetron for postoperative nausea and vomiting. Choi EM; Lee MG; Lee SH; Choi KW; Choi SH Anaesthesia; 2010 Oct; 65(10):996-1000. PubMed ID: 20707787 [TBL] [Abstract][Full Text] [Related]
16. Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists. Babaoglu MO; Bayar B; Aynacioglu AS; Kerb R; Abali H; Celik I; Bozkurt A Clin Pharmacol Ther; 2005 Dec; 78(6):619-26. PubMed ID: 16338277 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 2D6 metabolism and 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Janicki PK Med Sci Monit; 2005 Oct; 11(10):RA322-8. PubMed ID: 16192915 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis. Singh PM; Borle A; Gouda D; Makkar JK; Arora MK; Trikha A; Sinha A; Goudra B J Clin Anesth; 2016 Nov; 34():459-82. PubMed ID: 27687434 [TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in the cytochrome P450 system and efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Nielsen M; Olsen NV Br J Anaesth; 2008 Oct; 101(4):441-5. PubMed ID: 18782884 [No Abstract] [Full Text] [Related]
20. Prevention and treatment of postoperative nausea and vomiting. Kovac AL Drugs; 2000 Feb; 59(2):213-43. PubMed ID: 10730546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]